Author pages are created from data sourced from our academic publisher partnerships and public sources.
A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer.
BACKGROUND Screening for prostate cancer (PC) is controversial due to uncertainties about its efficiency. OBJECTIVE We aimed to develop strategies to reduce the number of unnecessary biopsies while… Expand
Prostate cancer detection at low prostate specific antigen.
- F. Schroeder, I. W. van der Cruijsen-Koeter, H. D. de Koning, A. Vis, R. Hoedemaeker, R. Kranse
- The Journal of urology
- 1 March 2000
PURPOSE At low prostate specific antigen (PSA) the indication for prostate biopsy is usually an abnormal digital rectal examination. We evaluate the diagnostic value of PSA, digital rectal… Expand
Identification of Genetic Markers for Prostatic Cancer Progression
Despite the high incidence of prostate cancer, only limited data are available on genes or chromosomes specifically involved in its initiation and progression. We have applied comparative genomic… Expand
Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.
- F. Schroeder, P. van der Maas, +4 authors R. Kranse
- Journal of the National Cancer Institute
- 1 July 1999
BACKGROUND The utility of digital rectal examination (DRE) as a screening test for early detection of prostate cancer has not been established. Therefore, we evaluated the usefulness of DRE as a… Expand
Computer-controlled wheelchair ergometer
- R. Niesing, F. Eijskoot, +5 authors C. Snijders
- Mathematics, Medicine
- Medical and Biological Engineering and Computing
- 1 July 1990
A new wheelchair ergometer has been designed in which a combination of realistic simulation of wheelchair propulsion—with adjustable parameters for rolling resistance, air drag, wind speed and… Expand
Large‐scale randomized prostate cancer screening trials: Program performances in the European randomized screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trial
- H. D. de Koning, A. Auvinen, +10 authors F. Schroeder
- International journal of cancer
- 10 January 2002
Two large‐scale randomized screening trials, the Prostate, Lung, Colorectal and Ovary (PLCO) cancer trial in the USA and the European Randomized Screening for Prostate Cancer (ERSPC) trial in Europe… Expand
Evaluation of the Digital Rectal Examination as a Screening Test for Prostate Cancer
Background: The utility of digital rectal examination (DRE) as a screening test for early detection of prostate cancer has not been established. Therefore, we evaluated the usefulness of DRE as a… Expand
Complications of transrectal ultrasound-guided systematic sextant biopsies of the prostate: evaluation of complication rates and risk factors within a population-based screening program.
OBJECTIVES Screening for prostate cancer to reduce the mortality and morbidity from this disease has become an important issue in recent years. Of all procedures used to diagnose prostate cancer,… Expand
Histopathological prostate cancer characteristics at radical prostatectomy after population based screening.
- R. Hoedemaeker, J. Rietbergen, R. Kranse, F. Schroeder, T. van der Kwast
- The Journal of urology
- 1 August 2000
PURPOSE Although early detection of prostate cancer by prostate specific antigen based screening results in a shift towards more clinically organ confined tumors, changes in prostate cancer… Expand
Screening for prostate cancer: results of the Rotterdam section of the European randomized study of screening for prostate cancer.
BACKGROUND Evidence from randomized trials on the effects of screening for prostate cancer (PCa) on disease-specific mortality accumulates slowly with increasing follow-up. OBJECTIVE To assess data… Expand